Search Results 131-140 of 16877 for Amphotericin B

  1. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  2. Publications - William R. G. Perry, M.B., Ch.B., M.P.H. - Mayo Clinic

    Ferrari D, Peponis T, Violante T, Cheng JN, Perry WR, Larson DW, Behm KT. Single-port robotic transanal minimally invasive surgery (SPR-TAMIS): another ...

  3. Publications - Anna B. Shapiro, M.D. - Mayo Clinic

    Huespe I, Sosa FA, Jena A, Pareek A, Saleem F, Bateh S, Andrade LB, Oribe BT, Daldoss F, Soto JS, Delgado J, Raavi L, Jonna S, Garcia B, Ivulich D, ...

  4. A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML - Mayo Clinic

    The purpose of this study is to determine the safety and preliminary efficacy of voruciclib as monotherapy in subjects with relapsed or refractory B-cell ...

  5. Drugs and Supplements that Start with H - Mayo Clinic

    Habitrol. Also known as · HAD. Also known as · Hadlima. Also known as · Hadlima. Also known as · Haegarda. Also known as · Haemophilus b conjugate and hepatitis b ...

  6. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  7. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple ...

  8. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

    SLL is a B-cell cancer found only in lymph nodes. Ibrutinib is an oral pill that blocks Bruton's tyrosine kinase (BTR), making the cancer vulnerable to death. “ ...

  9. A Study Testing The Combination Of Dasatinib Or Imatinib To Chemotherapy Treatment With Blinatumomab For Children, Adolescents, And Young Adults With Philadelphia Chromosome Positive (Ph+) Or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) - Mayo Clinic

    Giving blinatumomab and dasatinib or imatinib in combination with standard chemotherapy may work better in treating patients with Ph+ or Ph-like ABL-class B-ALL ...

  10. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    ... B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B that has come back (relapsed) or did not respond to the ...